newsfilter
← Latest News
GlobeNewswire·

Vaxxinity Reports First Quarter 2023 Financial Results and Provides Corporate Update

CAPE CANAVERAL, Fla., May 09, 2023 (GLOBE NEWSWIRE) -- Vaxxinity, Inc. (NASDAQ:VAXX), a U.S. company pioneering the development of a new class of immunotherapeutic vaccines, today reported financial results for the